TAUB MALCOLM S 4
4 · BRAINSTORM CELL THERAPEUTICS INC · Filed Jul 25, 2011
Insider Transaction Report
Form 4
TAUB MALCOLM S
Director
Transactions
- Award
Common Stock
2010-05-06+100,000→ 100,000 total - Award
Common Stock
2011-06-27+130,000→ 338,333 total - Sale
Common Stock
2011-07-08$0.46/sh−100,000$45,540→ 238,333 total - Award
Common Stock
2011-06-27+108,333→ 208,333 total
Footnotes (3)
- [F1]Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics 2005 Stock Option and Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on July 27, 2011 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.
- [F2]Shares acquired are shares of restricted stock automatically awarded on June 27, 2011 pursuant to the Brainstorm Cell Therapeutics Inc. Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on July 27, 2011 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.
- [F3]The transaction was executed in multiple trades at prices ranging from $0.4505 to $0.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.